MOH — authorised 7 May 1982
- Marketing authorisation holder: TEVA PHARMS USA
- Status: likely_approved
MOH authorised Zanosar on 7 May 1982
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 7 May 1982.
TEVA PHARMS USA holds the Israeli marketing authorisation.